McDevitt D G
Eur J Clin Pharmacol. 1985;28 Suppl:35-8. doi: 10.1007/BF00543708.
Tests of psychometric function were performed in young, normal volunteers taking several beta-adrenoceptor antagonists. With single doses of atenolol, a cardioselective hydrophilic beta-blocker, dose-dependent effects were apparent and were maximal at a dose of 200 mg. The lipophilic non-selective beta-blocker, propranolol, also produced significant impairment of psychomotor tests but these were inversely related to dose, the longest effects being at a dose of 40 mg but with little effect at 320 mg. Subsequently, a multisubject comparison of propranolol and atenolol confirmed these findings and showed the effects to be of the same order of magnitude as those produced by diazepam. Chronic administration of atenolol 100 mg, nadolol 80 mg and diazepam 5 mg daily for seven days showed some effects with all drugs during the test period; however, these were sporadic rather than persistent. Overall, beta-blockers do appear to have central effects in man which can be demonstrated by psychomotor tests. However, the relevance of these central effects to maintenance therapy and skilled performance is unclear.
对服用多种β-肾上腺素能受体拮抗剂的年轻正常志愿者进行了心理测量功能测试。使用单剂量的阿替洛尔(一种心脏选择性亲水性β受体阻滞剂)时,剂量依赖性效应明显,在200毫克剂量时达到最大。亲脂性非选择性β受体阻滞剂普萘洛尔也对精神运动测试产生了显著损害,但这些损害与剂量呈负相关,最长效应出现在40毫克剂量时,而在320毫克剂量时几乎没有效果。随后,对普萘洛尔和阿替洛尔进行的多受试者比较证实了这些发现,并表明这些效应与地西泮产生的效应在同一数量级。每天服用100毫克阿替洛尔、80毫克纳多洛尔和5毫克地西泮,持续七天,在测试期间所有药物都显示出一些效应;然而,这些效应是零星的,而非持续的。总体而言,β受体阻滞剂在人体中似乎确实具有中枢效应,这可以通过精神运动测试得到证明。然而,这些中枢效应与维持治疗和熟练操作的相关性尚不清楚。